Navigation Links
Jharkhand man turns beggar to pay hospital bill

A man in Jharkhand has turned to begging in order to pay his wife's medical bills at a Jamshedpur hospital// .

Anwar's wife Mehrunisa was admitted to the Tata Memorial Hospital in May after being critically ill, local media reports said. After treatment, she was declared fit on June 12. However, the couple were shocked to receive a whopping Rs.22,000 bill - an amount beyond Anwar's economic capacity.

The couple were then prevented from leaving the hospital unless they paid the entire amount. With no other option in sight, Anwar, a daily wage labourer, started begging outside the hospital to raise the huge sum.

"I came here for my wife's treatment after taking a loan of Rs.4,000 from my neighbours. I don't know how I will pay the bills. I also have to repay the loans. I requested the hospital management to waive the amount, but they expressed their inability to do so," Anwar was quoted as saying by local media.

He said: "The hospital bill equals our annual income."

Mehrunisa is now desperate to meet her children. The couple has six children who stay at their ancestral home in Saraikela district, 100 km from Jamshedpur. "I want to meet my children. I have not seen them for the last one-and-half months," lamented Mehrunisa. The mother's pleas to meet her kids, however, have not brought about any change of heart in the hospital management.

Anwar wakes up early in the morning and starts begging at the gate of the hospital until nightfall. He has no idea how long he will have to beg to collect the required money, pay the bills and go back to home.
'"/>




Page: 1

Related medicine news :

1. Jharkhand reports 13,000 Malaria cases
2. Jharkhand To Have Mobile Hospital
3. Jharkhand Gives Health industry status
4. Jharkhand Pharmacies Refuse To Sell Viagra
5. Jharkhand Chemists to Boycott Viagra
6. Yoga Guru Ramdev Invited to Tap Ayurveda Potential by Jharkhand Govt
7. Ramdev Signs MOU With Jharkhand Govt To Set Up Ayurveda Hospital
8. Jharkhand Govt Tie Up With Ramdev To Preserve Rare Herbal Plants
9. Jharkhand To Host Chicken Festival
10. Jharkhand Faces Acute Shortage Of Life-saving Drugs
11. Druggists On Strike In Jharkhand To Protest Against VAT Anomalies
Post Your Comments:
(Date:12/16/2009)... Reinertsen has run marathons, competed in triathalons and appeared on ... News) -- Sarah Reinertsen likes to think of herself as ... two-legged world is how the 34-year-old triathlete likes to describe ... find her speaking to packed school auditoriums or posing nude ... on the cover of the latest ESPN Body ...
(Date:12/16/2009)... - TSO3 Inc. ("TSO3") (TSX: TOS) and 3M ... reached for 3M to be the exclusive supplier ... partnership with TSO3, an innovator in low temperature ... through the use of ozone, will include new ... global sales channel. This agreement, combined with recent ...
(Date:12/16/2009)... time it takes to obtain a bachelor degree, an individual ... , ... (Vocus) December 16, 2009 ... Report Card on Higher Education" by the National Center for ... outpaced price increases in other sectors of the economy.”¹ Since ...
(Date:12/16/2009)... approaching and what would be the perfect gift to give that ... Celebrity Beauty Engineer® and Licensed Esthetician Mary Schook introduces exceptional beauty ... feel their best! , ... (PRWEB) December 16, 2009 ... does a person get that special woman who has everything? Why ...
(Date:12/15/2009)... 15 The failure of the U.S. ... cut costs, much less the more effective direct ... latest example of how big industry controls the ... proposed drug amendment by Senator Dorgan (D-ND) was ... campaign pledge to allow Medicare to directly negotiate ...
Breaking Medicine News(10 mins):Health News:Amputee Athlete Tells Her Story 2Health News:Amputee Athlete Tells Her Story 3Health News:Amputee Athlete Tells Her Story 4Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 2Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 3Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 4Health News:Career in Eye Care Practical Compared to Rising Tuition Costs 2Health News:Career in Eye Care Practical Compared to Rising Tuition Costs 3Health News:Career in Eye Care Practical Compared to Rising Tuition Costs 4Health News:Career in Eye Care Practical Compared to Rising Tuition Costs 5Health News:New Online Beauty Store Suggests Stem Cells for the Woman Who Has Everything 2Health News:Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industry's Controlling Hand in Health Reform Debate, According to Consumer Watchdog 2Health News:Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industry's Controlling Hand in Health Reform Debate, According to Consumer Watchdog 3
... published in BJOG: An International Journal of Obstetrics and ... praevia and placental abruption during the subsequent pregnancies ... ,Placental praevia is defined as the implantation ... of the cervix. Placenta abruption is the premature separation ...
... Nutrition Coalition on Tuesday launched a campaign to encourage ... . The obesity rate for U.S. Hispanics increased from ... are more likely to be obese and two times ... not Hispanic, the AP/Star reports. ,LNC's ...
... Bereaved families of firefighters who lost their lives to work- ... relief at last. Ontarios new labor laws state that they ... in order to qualify for compensation due the dead workers ... identify eight types of cancer that will be presumed to ...
... administration in the US. A Defence Department panel has ... posing a serious challenge on two fronts. ,One, ... problems. Second at the current level of staffing and funds, ... those affected necessary statement. ,In a damning revelation, ...
... peels, facelifts, there is no dearth of "anti-aging" products and ... and more American women go for them not just to ... order to be competitive enough in the market place, many ... of the botulinum toxin. The toxin blocks the transmission of ...
... schoolchildren, available data says. The question is whether early exposure ... of scientists from the King's College London and doctors ... seven-year study and hope to rope in 480 children in ... between four and 11 months and already have eczema or ...
Other Medicine News:Health News:Placental Problems in Women Linked With Caesarean Section 2Health News:Ontario Grants Fast-Track Compensation Rights for Work-Related Illnesses 2Health News:Ontario Grants Fast-Track Compensation Rights for Work-Related Illnesses 3Health News:One Third of US Troops Suffer from Mental Health Problems 2Health News:One Third of US Troops Suffer from Mental Health Problems 3Health News:More and More American Women Go for Facelifts to Get Jobs 2Health News:UK Scientists to Undertake Seven Year Study of Peanut Allergy 2
(Date:12/16/2009)... -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ... Phase 3 registration clinical trial for KRX-0401 ... relapsed / refractory multiple myeloma patients. ,, ... Study to Assess the Efficacy and Safety ... Bortezomib (Velcade®) and Dexamethasone in Multiple Myeloma ...
(Date:12/16/2009)... , - MIVI-TRUST ... Total of Over,640 patients Ahead of Schedule ... (Euronext Brussels: THR), a biopharmaceutical company,focused on ... for eye,disease, vascular disease and cancer, announces ... the second Phase III trial evaluating microplasmin ...
(Date:12/15/2009)... Immucor, Inc. (Nasdaq: BLUD ), a global leader ... industry, today announced that it will release its fiscal ... after the market close. The Company will host a ... a.m. (Eastern Time) to discuss the results. ... call by dialing 1-888-324-9321 (Passcode: BLUD). Investors can also ...
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 2Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 3Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 4Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 5Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 6Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 7ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 2ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 3ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 4RES Q Labor Resource Management Scores the Highest Among Staff Nurse Scheduling System Solutions Analyzed in the 2009 KLAS Mid term Performance Review 51064 1RES Q Labor Resource Management Scores the Highest Among Staff Nurse Scheduling System Solutions Analyzed in the 2009 KLAS Mid term Performance Review 51064 2Versus Technology Inc Announces Sale of Real Time Location System to the St Louis VA Medical Center 51059 1Versus Technology Inc Announces Sale of Real Time Location System to the St Louis VA Medical Center 51059 2Versus Technology Inc Announces Sale of Real Time Location System to the St Louis VA Medical Center 51059 3Actor Chris Noth to Share Story of Loss in National Life Insurance Awareness Month 51054 1Actor Chris Noth to Share Story of Loss in National Life Insurance Awareness Month 51054 2Actor Chris Noth to Share Story of Loss in National Life Insurance Awareness Month 51054 3
... Shire plc (LSE: SHP, Nasdaq: SHPGY ), the ... that coadministration of the ADHD medication VYVANSE(R) (lisdexamfetamine dimesylate) CII ... (20 mg X 2), did not alter the median time ... to be reached in the subjects evaluated. In the ...
... trials begin enrollment in May 2009; Reinforces Lilly,s commitment ... 21 Eli Lilly and Company (NYSE: ... this month in two separate but identical Phase III ... an anti-amyloid beta monoclonal antibody being investigated as a ...
Other Medicine Technology:New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 2New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 3New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 4New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 5New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 6New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 7New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 8Lilly Advances Second Alzheimer's Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials 2Lilly Advances Second Alzheimer's Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials 3Lilly Advances Second Alzheimer's Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials 4Lilly Advances Second Alzheimer's Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials 5
The ABI PRISM 3100 Genetic Analyzer, a multi-color fluorescence-based DNA analysis system with 16 capillaries operating in parallel, offers high-quality data and efficient sample processing for the b...
... latest 3-part differential analyzer based on the ... the CELL-DYN line. Offering 18 parameters and ... CELL-DYN 1800 meets the needs to today's ... than its predecessors and fits under standard ...
... QC Manager Point-of-Care Data Management System provides ... Glucose Testing System and the Precision PCx. ... automated way to collect, analyze, and report ... It provides an essential laboratory tool for ...
... Test is a color immunochromatographic assay using ... labeled color particles coated at two separate ... greater sensitivity than the conventional single label ... procedure, a throat swab is subjected to ...
Medicine Products: